… with Parkinson’s disease (PD) has never been more important to our mission. Learn how the power of community is moving Parkinson’s research forward and how it …

… Study Rationale:   Parkinson’s disease (PD) symptoms and progression vary greatly, making each Parkinson’s … Identifying these factors will help researchers predict how Parkinson’s progression in each case. Also, targeting processes that influence these factors could give …

… and experimental animal studies implicate neuroinflammatory mechanisms in the progressive death of midbrain … the progressive degeneration of the nigrostriatal pathway. However, since protein-based inhibitors have relatively … be advanced to clinical trials expediently. Anticipated Outcome: These studies will enable us to determine the critical …

… disease. Developing a new therapeutic can cost up to 2.6 billion dollars and takes many years of screening, … nationwide Norwegian prescription database, which includes comprehensive information about 600 million prescriptions … time-lag and sensitivity analyses. Our preliminary data show the feasibility of this approach as we associated beta …

… with Parkinson’s seven years ago at age 52, Jay refuses to let the disease define his limits. Instead, he’s training … . “This challenge isn’t just about me, it’s about showing what’s possible with Parkinson’s,” he says.  At … today, then I believe I can do six miles tomorrow.”  That commitment also led him to Rock Steady Boxing , an exercise …

… Photo courtesy of "New York Times Magazine." Michael J. Fox sat … of questions and answers, Michael talked at length about how he stays positive while navigating a chronic illness, … Parkinson's. Someone is saying your life is going to be completely changed. Yeah? When? I'm fine now but back then I …